Application
Host: RabbitTarget Name: FHL1Sample Type: Human Fetal HeartLane A: Primary AntibodyLane B: Primary Antibody + Blocking PeptidePrimary Antibody Concentration: 1ug/mlPeptide Concentration: 5ug/mlLysate Quantity: 25ug/lane/laneGel Concentration: 0.12Application
WB Suggested Anti-FHL1 Antibody Titration: 0.1ug/mlELISA Titer: 1:312500Positive Control: Human MuscleApplication
Human kidney| Product Name | Rabbit anti-FHL1 polyclonal antibody - C-terminal region |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | KYOT, SLIM, FHL-1, FHL1A, FHL1B, FLH1A, SLIM1, XMPMA, SLIM-1, SLIMMER |
| Immunogen | The immunogen for anti-FHL1 antibody: synthetic peptide directed towards the C terminal of human FHL1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:500~1:2000 IHC:1:50~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | BovineDogGuinea PigHorseHumanMousePigRabbitRatSheep |
| Concentration | 1mg/ml |
| Purification | Protein A |
| Gene Symbol | FHL1 |
|---|---|
| Gene Synonyms | FHL1 |
| Gene Full Name | Four and a half LIM domains 1 |
| Gene Summary | LIM proteins, named for 'LIN11, ISL1, and MEC3,' are defined by the possession of a highly conserved double zinc finger motif called the LIM domain. FHL1 may play an important role during the early stages of skeletal muscle differentiation, specifically in alpha5beta1-integrin-mediated signaling pathways. |
| Alternative Names | KYOT SLIM FHL-1 FHL1A FHL1B FLH1A SLIM1 XMPMA SLIM-1 SLIMMER |
| Molecular Weight(MW) | 32kDa |
| Sequence | 280 amino acids |
Application
Host: RabbitTarget Name: FHL1Sample Type: Human Fetal HeartLane A: Primary AntibodyLane B: Primary Antibody + Blocking PeptidePrimary Antibody Concentration: 1ug/mlPeptide Concentration: 5ug/mlLysate Quantity: 25ug/lane/laneGel Concentration: 0.12
Application
WB Suggested Anti-FHL1 Antibody Titration: 0.1ug/mlELISA Titer: 1:312500Positive Control: Human Muscle
Application
Human kidney| Application Notes | WB:1:500~1:2000 IHC:1:50~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
